Litcius/Paper detail

NDC80 Enhances Cisplatin-resistance in Triple-negative Breast Cancer

Jing Li, Xiaoqin Xu, Xiting Peng

2022Archives of Medical Research25 citationsDOI

Topics & Concepts

CisplatinTriple-negative breast cancerCancer researchChemotherapyOncologyBiologyBreast cancerCancerInternal medicineMedicinePARP inhibition in cancer therapyFerroptosis and cancer prognosisRetinoids in leukemia and cellular processes
NDC80 Enhances Cisplatin-resistance in Triple-negative Breast Cancer | Litcius